Analysis using the Oncomine and GEPIA databases has shown that overexpression of MRPS12 is associated with poorer OS in ovarian cancer patients, especially in those with advanced stages (III+IV), serous ovarian cancer, and TP53 mutations (117). The gene discussed is MRPS12; the disease is ovarian carcinoma.